Abstract: The present invention provides a Chinese herb composition for the treatment of macular degeneration and its preparation method. The composition comprises Salviae miltiorrhizae, Chuanxiong rhizoma, Lycii fructus, Chrysanthemi flos, Schisandrae chinensis fructus, Imperatae rhizoma, and Scutellariae radix, where the number of units by weight are: 0.8-3.0 units of Salviae miltiorrhizae, 0.3-2.0 units of Chuanxiong rhizoma, 0.6-2.4 units of Lycii fructus, 0.5-2.0 units of Chrysanthemi flos, 0.2-1.2 units of Schisandrae chinensis fructus, 0.9-6.0 units of Imperatae rhizoma, and 0.5-2.0 units of Scutellariae radix. The preparation method includes taking concentrated powder of each ingredient according to the number of units prescribed and mixing them together. The Chinese herb composition, conveniently delivered orally or parenterally, has been clinically proven to be safe and effective for all types of macular degeneration regardless of wet or dry forms.

Abstract: The present invention provides a Chinese herb composition for the treatment of macular degeneration and its preparation method. The composition comprises Salviae miltiorrhizae, Chuanxiong rhizoma, Lycii fructus, Chrysanthemi flos, Schisandrae chinensis fructus, Imperatae rhizoma, and Scutellariae radix, where the number of units by weight are: 0.8-3.0 units of Salviae miltiorrhizae, 0.3-2.0 units of Chuanxiong rhizoma, 0.6-2.4 units of Lycii fructus, 0.5-2.0 units of Chrysanthemi flos, 0.2-1.2 units of Schisandrae chinensis fructus, 0.9-6.0 units of Imperatae rhizoma, and 0.5-2.0 units of Scutellariae radix. The preparation method includes taking concentrated powder of each ingredient according to the number of units prescribed and mixing them together. The Chinese herb composition, conveniently delivered orally or parenterally, has been clinically proven to be safe and effective for all types of macular degeneration regardless of wet or dry forms.